search
Back to results

Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria (POMEC)

Primary Purpose

Gestational Diabetes

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
IADPSG Criteria
NDDG Criteria
Sponsored by
Hospital Mutua de Terrassa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Gestational Diabetes

Eligibility Criteria

18 Years - 50 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 18-50 years
  • No expectation that subject will be moving out of the area of the clinical center during the next year
  • Informed Consent Form signed by the subject

Exclusion Criteria:

  • Preexisting type 1 or 2 diabetes
  • Advanced HIV( on medications that cause hyperglycemia), severe liver disease, gastric bypass surgery or other illness/surgeries that preclude them from drinking the glucose solution.

Sites / Locations

  • Hospital Universitari Mutua TerrassaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

One-step:IADPSG Criteria

Two-step:NDDG Criteria

Arm Description

Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gr oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.

Step 1: Perform a 1h 50-g glucose load test (nonfasting. If the plasma glucose level measured 1 h after the load is 140 mg/dL, proceed to a 100-g OGTT. Step 2: 100-g OGTT. The diagnosis of GDM is made if at least two of the following four plasma glucose levels(measured fasting and 1 h, 2 h, 3 h after the OGTT) are met or exceeded: 105mg/dl, 190mg/dl, 165mg/dl and 145mg/dl respectively

Outcomes

Primary Outcome Measures

Large for gestational age
Infant birthweight >90th centile using customized growth curves

Secondary Outcome Measures

Macrosomia
infant birthweight >=4kg
Small for gestational age
infant birthweight <10th centile using customized growth curves
Hypertension in pregnant
classification according to American College of Obstetricians and Gynecologists (Task Force on Hypertension in Pregnancy).
Neonatal obstetric trauma
rate of shoulder dystocia, clavicle fracture, brachial plexus injury and intrapartum asphyxia
Congenital anomalies
Coding of EUROCAT
Neonatal hypoglycemia
neonatal plasma glucose levels of <2.5 mmol/L in the first 24 hours of life and <2.8 mmol/L thereafter.
Neonatal hypocalcemia
neonatal calcium levels of <7mg/dl
Neonatal hyperbilirubinemia
hyperbilirubinemia treated with phototherapy
Neonatal polycythemia
hematocrit from a peripheral venous sample is >65 percent
Respiratory Distress Syndrome
onset of progressive respiratory failure shortly after birth, in conjunction with a characteristic chest radiograph (after ruling out other causes).
Infant Outcomes
Pregnancy loss (Miscarriage, stillbirth, neonatal death)
Hypertrophic cardiomyopathy
increased left ventricular (LV) wall thickness ≥15 mm is imaged anywhere in the LV wall (by transthoracic echocardiography)
Polyhydramnios
Amniotic fluid index ≥25 cm
Gestational age at delivery
Gestational age was defined as completed weeks based on last menstrual period or the earliest ultrasound assessment if discordant.
Cesarean section
delivery of a baby through a surgical incision in the mother's abdomen and uterus
Perinatal mortality
infant deaths that occur at less than 7 days of age and fetal deaths with a gestational age of 28 weeks or more.
NICU admission
NICU admission for treatment or surveillance
Maternal hospital stay
Length of hospital stay (days)
Neonatal hospital stay
Length of hospital stay (days)
Evaluation of mediterranean diet adherence
using Mediterranean Diet Adherence Screener (MEDAS) questionnaire. Score betwwen 0-14; high score indicate maximum mediterranean diet adherence.
Evaluation of health-related physical activity
using International Physical Activity Questionnaire (IPAQ). Data collected with IPAQ can be used as a continuous measure (Metabolic Equivalent of Task [MET]-minutes/week) or caterorical measure (low, moderate or high physical activity)
Medical cost
Economic cost include: laboratory costs; glucose bottles (50 g, 100 g and 75 g); pharmaceutical expenditure (exact insulin doses consumed, total pens, needles, strips); medical visits during pregnany and postpartum (endocrinologist,educational nurses, obstetrician and midwifes); total number of tests (ultrasonds, cardiotocography record); cost of intensive care unit admissions (Length of stay and complexity) and total hospital admission costs. All these variables will be expressed as cost (€).

Full Information

First Posted
November 27, 2017
Last Updated
January 29, 2018
Sponsor
Hospital Mutua de Terrassa
search

1. Study Identification

Unique Protocol Identification Number
NCT03421262
Brief Title
Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria
Acronym
POMEC
Official Title
Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria: Randomized Prospective Study.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Unknown status
Study Start Date
June 1, 2017 (Actual)
Primary Completion Date
November 27, 2018 (Anticipated)
Study Completion Date
December 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Mutua de Terrassa

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the study is to evaluate differences in pregnancy outcomes and medical costs depending on gestational diabetes diagnostic criteria used (one vs two-step approach).
Detailed Description
Due to Hyperglycemia and Adverse Pregnancy Outcomes study results, a new gestational diabetes mellitus (GDM) diagnostic criteria was defined using a one-step approach (75-g oral glucose tolerance test -OGTT-). However, not all scientific societies have accepted and have implanted this new diagnostic criteria. The lowest glycemia cut-off of this criteria regarding the two-step approach entails an increase in GDM incidence with discordant studies about its cost-effectivity. It will be assessed if pregnancy outcomes and medical costs are different depending on diagnostic criteria used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3644 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
One-step:IADPSG Criteria
Arm Type
Experimental
Arm Description
Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gr oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.
Arm Title
Two-step:NDDG Criteria
Arm Type
Active Comparator
Arm Description
Step 1: Perform a 1h 50-g glucose load test (nonfasting. If the plasma glucose level measured 1 h after the load is 140 mg/dL, proceed to a 100-g OGTT. Step 2: 100-g OGTT. The diagnosis of GDM is made if at least two of the following four plasma glucose levels(measured fasting and 1 h, 2 h, 3 h after the OGTT) are met or exceeded: 105mg/dl, 190mg/dl, 165mg/dl and 145mg/dl respectively
Intervention Type
Diagnostic Test
Intervention Name(s)
IADPSG Criteria
Intervention Description
One-step: 2 hr 75 gr OGTT
Intervention Type
Diagnostic Test
Intervention Name(s)
NDDG Criteria
Intervention Description
Osullivan test + 3 h 100 g OGTT
Primary Outcome Measure Information:
Title
Large for gestational age
Description
Infant birthweight >90th centile using customized growth curves
Time Frame
At birth of infant
Secondary Outcome Measure Information:
Title
Macrosomia
Description
infant birthweight >=4kg
Time Frame
At birth of infant
Title
Small for gestational age
Description
infant birthweight <10th centile using customized growth curves
Time Frame
At birth of infant
Title
Hypertension in pregnant
Description
classification according to American College of Obstetricians and Gynecologists (Task Force on Hypertension in Pregnancy).
Time Frame
First 3 months postpartum
Title
Neonatal obstetric trauma
Description
rate of shoulder dystocia, clavicle fracture, brachial plexus injury and intrapartum asphyxia
Time Frame
At birth of infant
Title
Congenital anomalies
Description
Coding of EUROCAT
Time Frame
At birth of infant
Title
Neonatal hypoglycemia
Description
neonatal plasma glucose levels of <2.5 mmol/L in the first 24 hours of life and <2.8 mmol/L thereafter.
Time Frame
up to 4 weeks after delivery
Title
Neonatal hypocalcemia
Description
neonatal calcium levels of <7mg/dl
Time Frame
up to 4 weeks after delivery
Title
Neonatal hyperbilirubinemia
Description
hyperbilirubinemia treated with phototherapy
Time Frame
up to 4 weeks after delivery
Title
Neonatal polycythemia
Description
hematocrit from a peripheral venous sample is >65 percent
Time Frame
up to 4 weeks after delivery
Title
Respiratory Distress Syndrome
Description
onset of progressive respiratory failure shortly after birth, in conjunction with a characteristic chest radiograph (after ruling out other causes).
Time Frame
up to 4 weeks after delivery
Title
Infant Outcomes
Description
Pregnancy loss (Miscarriage, stillbirth, neonatal death)
Time Frame
up to 4 weeks after delivery
Title
Hypertrophic cardiomyopathy
Description
increased left ventricular (LV) wall thickness ≥15 mm is imaged anywhere in the LV wall (by transthoracic echocardiography)
Time Frame
up to 4 weeks after delivery
Title
Polyhydramnios
Description
Amniotic fluid index ≥25 cm
Time Frame
At birth of infant
Title
Gestational age at delivery
Description
Gestational age was defined as completed weeks based on last menstrual period or the earliest ultrasound assessment if discordant.
Time Frame
At birth of infant
Title
Cesarean section
Description
delivery of a baby through a surgical incision in the mother's abdomen and uterus
Time Frame
At birth of infant
Title
Perinatal mortality
Description
infant deaths that occur at less than 7 days of age and fetal deaths with a gestational age of 28 weeks or more.
Time Frame
First 7days postpartum
Title
NICU admission
Description
NICU admission for treatment or surveillance
Time Frame
up to 4 weeks after delivery
Title
Maternal hospital stay
Description
Length of hospital stay (days)
Time Frame
up to 4 weeks from maternal discharge
Title
Neonatal hospital stay
Description
Length of hospital stay (days)
Time Frame
up to 4 weeks from neonatal discharge
Title
Evaluation of mediterranean diet adherence
Description
using Mediterranean Diet Adherence Screener (MEDAS) questionnaire. Score betwwen 0-14; high score indicate maximum mediterranean diet adherence.
Time Frame
up to 12-14weeks from last menstrual period.
Title
Evaluation of health-related physical activity
Description
using International Physical Activity Questionnaire (IPAQ). Data collected with IPAQ can be used as a continuous measure (Metabolic Equivalent of Task [MET]-minutes/week) or caterorical measure (low, moderate or high physical activity)
Time Frame
up to 12-14weeks from last menstrual period.
Title
Medical cost
Description
Economic cost include: laboratory costs; glucose bottles (50 g, 100 g and 75 g); pharmaceutical expenditure (exact insulin doses consumed, total pens, needles, strips); medical visits during pregnany and postpartum (endocrinologist,educational nurses, obstetrician and midwifes); total number of tests (ultrasonds, cardiotocography record); cost of intensive care unit admissions (Length of stay and complexity) and total hospital admission costs. All these variables will be expressed as cost (€).
Time Frame
First 3 months postpartum

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18-50 years No expectation that subject will be moving out of the area of the clinical center during the next year Informed Consent Form signed by the subject Exclusion Criteria: Preexisting type 1 or 2 diabetes Advanced HIV( on medications that cause hyperglycemia), severe liver disease, gastric bypass surgery or other illness/surgeries that preclude them from drinking the glucose solution.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Verónica Perea, MD
Phone
0034937365050
Ext
11330
Email
vperea@mututaterrassa.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Verónica Perea, MD
Organizational Affiliation
Hospital Universitari Mutua Terrassa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitari Mutua Terrassa
City
Terrassa
State/Province
Barcelona
ZIP/Postal Code
08221
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Verónica Perea, MD
Phone
0034937365050
Ext
11330
Email
vperea@mutuaterrassa.cat

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18463375
Citation
HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008 May 8;358(19):1991-2002. doi: 10.1056/NEJMoa0707943.
Results Reference
background

Learn more about this trial

Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria

We'll reach out to this number within 24 hrs